Ameriprise Financial Inc Immunocore Holdings PLC Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$60.14 - $75.36 $73,611 - $92,240	1,224 Added 5.18%	24,866 $1.62 Million
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $4,285 - $6,950	-100 Reduced 0.42%	23,642 $1.62 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $3.63 Million - $4.89 Million	-73,403 Reduced 75.56%	23,742 $1.23 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $67,761 - $86,049	1,396 Added 1.46%	97,145 $5.82 Million
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $3.44 Million - $4.9 Million	74,637 Added 353.53%	95,749 $4.73 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $31,857 - $45,556	700 Added 3.43%	21,112 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $762,184 - $1.17 Million	20,412 New	20,412 $959,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.